A clinical phase II study assessing the safety and efficacy of readministration of bendamustine monotherapy or bendamustine/rituximab for relapsed low grade B cell non-Hodgkin lymphoma or mantle cell lymphoma patients previously treated with bendamustine containing chemotherapy.
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2015
At a glance
- Drugs Bendamustine (Primary) ; Rituximab (Primary)
- Indications B cell lymphoma; Mantle-cell lymphoma
- Focus Therapeutic Use
- 08 Jul 2013 New trial record